...
首页> 外文期刊>Intelligence: A Multidisciplinary Journal >Extracellular ATP and Purinergic P2Y(2) Receptor Signaling Promote Liver Tumorigenesis in Mice by Exacerbating DNA Damage
【24h】

Extracellular ATP and Purinergic P2Y(2) Receptor Signaling Promote Liver Tumorigenesis in Mice by Exacerbating DNA Damage

机译:细胞外ATP和嘌呤能P2Y(2)受体信号传导通过加剧DNA损伤来促进小鼠中的肝脏肿瘤

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Release of ATP to the extracellular compartment and subsequent activation of purinergic receptors is a conserved mechanism mediating inflammatory responses and cell fate decisions in various organs including the liver. Previous findings suggest that extracellular ATP may promote liver tumorigenesis, however, the underlying mechanisms are poorly understood. Therefore, our aim was to dissect the functions of extracellular ATP and P2Y(2) receptors (P2Y(2)R) during hepatocarcinogenesis. Liver tumors were induced in wild-type and P2y(2)r(-/-) knockout mice by intraperitoneal diethylnitrosamine (DEN) injection. Tumorigenesis was analyzed after 8 to 10 months and molecular analyses were performed at different stages of tumorigenesis in vivo, as well as in primary mouse hepatocytes in vitro. Liver tumor incidence and tumor numbers were strongly reduced in P2y(2)r(-/-) mice, whereas tumor size and morphology were comparable to wild-type controls, suggesting that P2(Y)2R contributes to tumor initiation. Mechanistically, hepatocyte proliferation in DEN-treated P2y(2)r(-/-) mice was reduced, which correlated with reduced c-JUN and CCND1 but increased p21 expression. Moreover, DNA damage as determined by hepatocellular expression of gH2A.X and of genes related to genotoxic stress, as well as STAT3 phosphorylation, was reduced in the absence of P2y(2)r. Administration of genotoxic agents to primary hepatocytes in vitro confirmed that DNA damage was indeed exacerbated by extracellular ATP, subsequent P2Y(2)R activation, and downstream intracellular calcium-dependent signal transduction. In conclusion, our data reveal that extracellular ATP and subsequent P2Y(2)R function stimulate DNA damage responses and hepatocyte proliferation, thereby promoting hepatocarcinogenesis. Targeting this pathway may be an attractive approach for chemoprevention of hepatocellular carcinoma.
机译:将ATP释放到细胞外隔室和后续嘌呤能受体的活化是介导炎症反应和细胞命运决策在包括肝脏的各种器官中的保守机制。以前的研究结果表明,细胞外ATP可以促进肝脏肿瘤内酯,但是,潜在的机制较差地理解。因此,我们的目标是将细胞外ATP和P2Y(2)受体(P2Y(2)R)的功能剖析肝癌发生期间。通过腹膜内二乙基腈(DEN)注射液体型和P2Y(2)R( - / - )敲除小鼠诱导肝脏肿瘤。在8至10个月后分析肿瘤鉴定,并且在体内肿瘤发生的不同阶段进行分子分析,以及在体外的原代小鼠肝细胞中进行。 P2Y(2)R( - / - )小鼠中强烈地减少了肝肿瘤发病率和肿瘤数,而肿瘤大小和形态与野生型对照相当,表明P2(Y)2R有助于肿瘤引发。机械地,降低了DEN处理的P2Y(2)R( - / - )小鼠中的肝细胞增殖,其与C-JUM和CCND1还原但增加了P21表达。此外,在没有P2Y(2)r的情况下,通过肝细胞表达和与遗传毒性应力相关的基因和与遗传毒性应激相关的基因确定的DNA损伤,以及STAT3磷酸化。将遗传毒剂施用于初级肝细胞体外证实,通过细胞外ATP,随后的P2Y(2)R活化和下游的细胞内钙依赖性信号转导进行DNA损伤。总之,我们的数据显示,细胞外ATP和随后的P2Y(2)R函数刺激DNA损伤反应和肝细胞增殖,从而促进肝癌发生。靶向该途径可能是肝细胞癌化学预防的有吸引力的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号